THE

GLOBAL HEALTHCARE STUDY ON PSORIASIS

The data-driven approach to mapping psoriasis globally.
 TABLE OF CONTENTS

01 02 03

PSORIASIS MY MOTIVATION THE GHSP

04 05

NEXT STEPS PERSPECTIVES

01
PSORIASIS
A BRIEF INTRODUCTION
TO PSORIASIS

• Common, chronic, systemic inflammatory skin disease

• Over 60 million people of all ages and in all countries are affected
• Different phenotypes (e.g., psoriasis vulgaris, guttata, pustulosa)
• Noncommunicable with no clear cause or cure

• Common comorbidities include, but are not limited to,

• Arthritis, cardiovascular diseases, metabolic-syndrome
• Mental disorders such as social anxiety and depression

• Often causes a great physical, emotional and social burden and a

substantial negative impact on people’s lives

• Incorrect or delayed diagnosis, inadequate treatment options and

insufficient access to care are common

Pictures provided by the Universitätsspital Zürich (USZ).

Not for further use.
WHO REPORT
YEAR 2016

CLOSING GAPS BY MEASURING

“... there are huge geographic gaps in knowledge, especially

from low- and middle-income settings. In order to compare the
incidence and prevalence of psoriasis between regions and to
track their trends over time, data must be obtained in the same
way in different places [and …] standardized measurements are
needed, including […] case-finding methods, in order to provide
further insight into dermatological problems such as psoriasis.”

World Health Organization. Global Report on Psoriasis.

WHO Library Cataloguing-in-Publication Data. 2020. ISBN: 9789241565189.
02
MY MOTIVATION
 ▪ Mexico City

▪ Panama City
AMERICA LATINA
YEAR 2018
▪ Bogotá
▪ Cali Chile
▪ Quito
▪ Cartagena Argentina
▪ Medellín Uruguay
Brazil
▪ Cusco Mexico
▪ Lima Bolivia
Peru
Ecuador
Columbia
Panama

▪ Cochabamba ▪ São Paulo

▪ La Paz and El Alto
▪ Santa Cruz de la Sierra
▪ Villa Tunari ▪ Porto Alegre

▪ Buenos Aires (AR)

▪ Colonia (UY)

▪ Santiago de Chile
 AMERICA LATINA
YEAR 2020
Chile
Brazil

▪ Curacaví
▪ Los Andes
▪ Santiago de Chile
▪ Valparaíso
▪ Viña del Mar ▪ Salvador

▪ Campinas
▪ São Paulo
▪ São Bernardo do Campo
▪ Osorno

▪ Florianópolis
GREENLAND
YEAR 2022
Iceland
Greenland

▪ Reykjavík

▪ Kulusku
▪ Tasiilaq
03
THE GHSP
 THE GHSP
GLOBAL HEALTHCARE STUDY ON PSORIASIS

GROWING NETWORK
 MAIN OBJECTIVES
OF THE GHSP

STRENGTHEN
the international network of
dermatologists and study
centers and enable them to
share their insights.

IDENTIFY & IMPROVE COMMUNICATE

the standard of and access to the study results through
publications in scientific
psoriasis care in as many journals, lectures, symposia,
countries around the globe and congresses.
as possible.
AGGREGATE
the collected data, establish
a data resource and make it
available to researchers of
all professions.
 PILOT STUDY
YEAR 2020
A cross-sectional
multi-center pilot study
1.431 psoriasis patients
from 43 study centers across
Chile (16 centers)
and Brazil (27 centers)
were included.

Pilot study in 2020

 ACTIVE
STUDY CENTERS
Brazil
Chile
China
Colombia
Nigeria
Peru
Singapore
Switzerland
United States

A prevalence study
was conducted 2022
in Greenland.

Pilot study in 2020 Actively collecting data

 INTERESTED
STUDY CENTERS
Argentina
Australia
Austria
Canada
Costa Rica
Denmark
Ecuador
Egypt
Guatemala
Israel
India
Philippines
South Africa
Spain
Tunisia
Taiwan
Tanzania
Zambia
among others …

Pilot study in 2020 Actively collecting data Interested to participate

04
NEXT STEPS
 UPCOMING MILESTONES
IN 2022 AND 2023

FY Q1 Q4
2022 2023 2023

Q4 Q2
2022 2023
PLATFORM INDEPENDENT
The GHSP is being conducted online, utilizing an
intuitive and easy to use, web-based software that is
tailored to the specific needs of the project. It is
optimized for the use on any desktop and/or mobile
device and supports multiple languages.
 THREE SURVEYS
CONSECUTIVE LEVELS OF DETAIL

COUNTRY LEVEL

INSTITUTION LEVEL

PATIENT LEVEL
05
PERSPECTIVES
 THE GHSP PROVIDES …
… robust, detailed multi-level data on
psoriasis that can be used for gender
medicine, translational research, health
economics and epidemiology.
 MEASURES OF SUCCESS
GOALS FOR 2023

ROBUST DATA FURTHER SUPPORT

We are confident to collect We would feel honored to
valuable insights on all three raise support and continue
levels of detail. the GHSP beyond 2023.

INCREASED REACH NEW STUDIES

We aim to grow our network We are looking forward to
beyond the boundaries of initiating new studies based
the GPA and the IPC. on the collected data.